Efficacy and safety of cilostazol-nimodipine combined therapy on delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: a prospective, randomised, double-blinded, placebo-controlled trial protocol

Introduction Delayed cerebral ischaemia (DCI) due to cerebral vasospasm (cVS) remains the foremost contributor to morbidity and mortality following aneurysmal subarachnoid haemorrhage (aSAH). Past efforts in preventing and treating DCI have failed to make any significant progress. To date, our most...

Full description

Bibliographic Details
Published in:BMJ Open
Main Authors: Chad F Claus, Doris Tong, Diana Sigler, Matthew Bahoura, Prashant Kelkar, Boyd Richards, Teck M Soo, Troy Dawley, Sina Rajamand, Lucas Garmo
Format: Article
Language:English
Published: BMJ Publishing Group 2020-10-01
Online Access:https://bmjopen.bmj.com/content/10/10/e036217.full